Trials / Active Not Recruiting
Active Not RecruitingNCT05731570
Cognitive Rehabilitation for People With Cognitive Covid19
Cognitive Impairment in Long Covid: PhEnotyping and RehabilitatiOn (CICERO)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- University College, London · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Cognitive impairment is increasingly recognised as a major component of long Covid, and is estimated to be present in 25-75% of affected individuals. This impairment impacts quality of life and the loss of functional ability has major consequences for affected people, their families and the wider economy given people's difficulty in returning to work. This study will focus on helping people recover from cognitive Covid. This will involve use of rehabilitation strategies aimed at improving function in those cognitive functions identified in Stage 1 as being most affected, and assessing the benefit of rehabilitation on quality of life and people's ability to return to everyday function. These strategies will be co-produced in collaboration with a group of people living with cognitive Covid. At the end of Stage 2 we will produce a freely available "Covid-19 Cognitive Recovery Guide" for affected people, their close contacts and clinicians. In conclusion, cognitive impairment is frequently observed in long Covid but at present little is understood about its nature, or how it can be treated. The sheer scale of the CV19 pandemic makes this a top priority unmet need for healthcare worldwide. The aim of this study is to meet this need and to deliver a treatment plan for affected people which will help them return to normal life and working ability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Cognitive rehabilitation | Set of restorative and compensatory strategies to rehabilitate cognitive function combined with emotional regulation techniques. |
Timeline
- Start date
- 2023-02-14
- Primary completion
- 2024-07-01
- Completion
- 2024-09-01
- First posted
- 2023-02-16
- Last updated
- 2024-06-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05731570. Inclusion in this directory is not an endorsement.